세계의 인플루엔자 진단 시장 : 규모, 점유율, 성장 분석, 제품별, 검사별, 최종 사용자별, 지역별 업계 예측(2024-2031년)
Influenza Diagnostics Market Size, Share, Growth Analysis, By Product (Test kit & Reagents, Instruments), By Test (Molecular Diagnostic Test, Transcription Mediated Amplification Based Assay), By End User, By Region - Industry Forecast 2024-2031
상품코드:1619084
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 165 Pages
라이선스 & 가격 (부가세 별도)
한글목차
인플루엔자 진단 세계 시장 규모는 2022년에 13억 달러로 평가되었고, 2023년 14억 달러에서 2031년에는 21억 달러로 성장하며, 예측 기간 중(2024-2031년) CAGR은 4.9%로 나타날 전망입니다.
헬스케어 지출 증가와 효과적인 치료의 진보가 세계 연령 중앙값의 상승에 기여하고 있습니다. WHO, CDC, 유럽 질병 예방 관리 센터(European Centre for Disease Prevention and Control)와 같은 규제 기관은 건강 문제를 체계적으로 해결하기 위해 이환율과 유병률 데이터를 열심히 추적하고 있습니다. Global Influenza Program(GIP)과 같은 공동 이니셔티브는 인플루엔자 및 관련 유행학을 관리하기 위한 기술적 지원과 전략적 지침을 강화하는 것을 목표로 합니다. 이러한 노력에도 불구하고 COVID-19 팬데믹은 제조 시설의 일시 폐쇄와 공급망의 혼란으로 이어져 독감 진단 시장에 큰 영향을 미쳤습니다. 또한 COVID-19와 인플루엔자의 증상이 유사하기 때문에 동시 검사가 필요하며, 이러한 과제 중 인플루엔자 진단에 대한 수요를 촉진하고 궁극적으로 예측 기간 동안이 시장 분야의 성장을 촉진합니다.
목차
소개
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터와 1차 데이터의 방법
시장 규모 예측
시장의 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
억제요인과 과제
Porter's Five Forces 분석과 영향
경쟁 기업간 경쟁 관계
대체품의 위협
구매자의 협상력
신규 진입업자의 위협
공급기업의 협상력
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2023년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
기술의 진보
규제 상황
사례 연구
특허 분석
인플루엔자 진단 시장 규모 : 제품별 및 CAGR(2024-2031년)
시장 개요
검사 키트 및 시약
기기
기타
인플루엔자 진단 시장 규모 : 검사별 및 CAGR(2024-2031년)
시장 개요
분자진단 검사
중합효소 연쇄반응
등온 핵산 증폭 검사
검사
전사 증폭법 베이스 검사
루프 매개 등온 증폭법 기반 검사
핵산 서열 기반 증폭 검사
기존 진단 검사
신속 인플루엔자 진단 검사
바이러스 배양 검사
직접 형광 항체 검사
혈청학적 검사
인플루엔자 진단 시장 규모 : 최종 사용자별 및 CAGR(2024-2031년)
시장 개요
진단 실험실
병원 및 진료소
기타
인플루엔자 진단 시장 규모 및 CAGR(2024-2031년)
북미
미국
캐나다
유럽
영국
독일
스페인
프랑스
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2023년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2023년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2021-2023년)
주요 기업 프로파일
Thermo Fisher Scientific(US)
Becton, Dickinson and Company(US)
F. Hoffmann-La Roche AG(Switzerland)
Hologic, Inc.(US)
Abbott Laboratories, Inc.(US)
DiaSorin(Italy)
QIAGEN NV(Netherlands)
Fujirebio Diagnostics, Inc.(Japan)
Meridian Bioscience, Inc.(US)
Luminex Corporation(US)
Seegene Inc.(South Korea)
Bio-Rad Laboratories, Inc.(US)
Alere Inc.(US)
GenMark Diagnostics, Inc.(US)
Roche Diagnostics(Switzerland)
BioMerieux SA(France)
Cepheid(US)
SD Biosensor(South Korea)
Acon Laboratories, Inc.(US)
Inverness Medical Innovations, Inc.(US)
결론과 권장사항
JHS
영문 목차
영문목차
Global Influenza Diagnostics Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.4 billion in 2023 to USD 2.1 billion by 2031, growing at a CAGR of 4.9% during the forecast period (2024-2031).
Rising healthcare expenditures and effective treatment advancements are contributing to a global increase in median age. Regulatory organizations such as WHO, CDC, and the European Centre for Disease Prevention and Control are diligently tracking incidence and prevalence data to systematically address health challenges. Collaborative initiatives like the Global Influenza Program (GIP) aim to enhance technical support and strategic guidance in managing influenza and related pandemics. Despite these efforts, the COVID-19 pandemic has significantly impacted the influenza diagnostics market, leading to temporary closures of manufacturing facilities and disruptions in supply chains. Furthermore, the similarities between COVID-19 and influenza symptoms necessitate concurrent testing, driving the demand for influenza diagnostics amidst these challenges, ultimately fostering growth in this market sector during the forecast period.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Influenza Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Influenza Diagnostics Market Segmental Analysis
Global Influenza Diagnostics Market is segmented by Product, Test, End User and Region. Based on Product, the market is segmented into Test kit and Reagents, Instruments, Other Products. Based on Test, the market is segmented into Molecular Diagnostic Test (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification, Tests), Transcription Mediated Amplification Based Assay, Loop Mediated Isothermal Amplification Based Assay, Nucleic Acid Sequence based Amplification Tests, Traditional Diagnostics Tests (Rapid Influenza Diagnostic Test, Viral Culture Test, Direct Fluorescent Antibody Test, Serological Tests). Based on End User, the market is segmented into Diagnostic Laboratories, Hospitals and Clinics, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Influenza Diagnostics Market
A key driver in the global Influenza Diagnostics market is the increased emphasis on research and development in this area. The escalating global incidence of influenza has intensified efforts to create accurate and rapid diagnostic methods for identifying influenza viruses. This focus on enhancing diagnostic capabilities is expected to significantly propel market growth. Furthermore, government initiatives aimed at combating influenza outbreaks, along with advancements in technology, are enhancing diagnostic efficacy. Additionally, the growing prevalence of related health issues, such as cardiovascular diseases and diabetes, will also contribute to the upward momentum of the Influenza Diagnostics market.
Restraints in the Global Influenza Diagnostics Market
The Global Influenza Diagnostics market faces several restraints, particularly the shortage of skilled technicians, which significantly hampers its growth potential. The scarcity of qualified professionals, compounded by an unstable regulatory environment regarding the approval of new diagnostic tests, poses a considerable challenge. Additionally, developing economies often struggle with inadequate healthcare infrastructure, further complicating the situation. As a result, these factors collectively hinder the market's expansion, making it more difficult to implement and utilize advanced diagnostic technologies effectively in the fight against influenza. Addressing these issues is crucial for fostering growth and improving diagnostic capabilities worldwide.
Market Trends of the Global Influenza Diagnostics Market
The global influenza diagnostics market is poised for substantial growth, driven by a notable rise in reported influenza cases worldwide. With the Centers for Disease Control and Prevention (CDC) estimating annual influenza-related fatalities in the U.S. between 12,000 and 79,000, the urgency for effective diagnostic solutions becomes ever more critical. Furthermore, heightened awareness surrounding the significance of early detection and proactive disease management is propelling demand for advanced testing technologies. As healthcare providers and patients prioritize timely intervention to mitigate influenza outbreaks, the market is expected to expand significantly during the forecast period, reflecting both public health imperatives and technological advancements in diagnostics.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Driver & Opportunities
Restraints & Challenges
Porters Analysis & Impact
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Patent Analysis
Influenza Diagnostics Market Size by Product & CAGR (2024-2031)
Market Overview
Test kit and Reagents
Instruments
Others
Influenza Diagnostics Market Size by Test & CAGR (2024-2031)
Market Overview
Molecular Diagnostic Test
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification
Tests
Transcription Mediated Amplification Based Assay
Loop Mediated Isothermal Amplification Based Assay
Nucleic Acid Sequence based Amplification Tests
Traditional Diagnostics Tests
Rapid Influenza Diagnostic Test
Viral Culture Test
Direct Fluorescent Antibody Test
Serological Test
Influenza Diagnostics Market Size by End User & CAGR (2024-2031)
